Maurits Brandt
Vice President
Novo HoldingsCopenhagen, Capital Region of Denmark, Denmark
16 investmentsMaurits Brandt is a Vice President at Novo Holdings based in Copenhagen, Capital Region of Denmark, Denmark. Maurits Brandt has backed 16 companies, including ProtAffin Biotechnologie, F-star Biotechnology and Orphazyme. Investment focus areas include Health Care, Genetics and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Health Care
Genetics
Wellness
Equities
Investment Management
Design
Infrastructure
Energy
Healthcare Innovation
Chemical
Life Science
Portfolio Management
Nordic Countries-based Startups
Medical Technologies
Finance
Biotechnology
Medical Devices
Genomics
Innovation
Utilities
Health Diagnostics
Social Impact
Renewable Energy
Medical
B2B
Real Estate
Therapeutics
Pharmaceuticals
Healthcare Technology
Portfolio Companies (16)
| 1 | ProtAffin Biotechnologie |
| 2 | F-star Biotechnology |
| 3 | Orphazyme |
| 4 | Affectis Pharmaceuticals |
| 5 | Hemab Therapeutics |
| 6 | Aquapharm Biodiscovery |
| 7 | to-BBB |
| 8 | i-Optics |
| 9 | EOS (Ethical Oncology Science) |
| 10 | Coave Therapeutics |
| 11 | ADCendo |
| 12 | Avantium Technologies |
Showing 1–12 of 16
Page 1 of 2
Access Full Contact Information
Get Maurits Brandt's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.